APA (7th ed.) Citation

BH, C., M, S., F, M., RA, C., G, K., N, C., . . . JS, S. (2007). Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: An open-label randomised trial. Lancet, 370(9600), 1698. https://doi.org/10.1016/s0140-6736(07)61605-5

Chicago Style (17th ed.) Citation

BH, Chi, et al. "Single-dose Tenofovir and Emtricitabine for Reduction of Viral Resistance to Non-nucleoside Reverse Transcriptase Inhibitor Drugs in Women Given Intrapartum Nevirapine for Perinatal HIV Prevention: An Open-label Randomised Trial." Lancet 370, no. 9600 (2007): 1698. https://doi.org/10.1016/s0140-6736(07)61605-5.

MLA (9th ed.) Citation

BH, Chi, et al. "Single-dose Tenofovir and Emtricitabine for Reduction of Viral Resistance to Non-nucleoside Reverse Transcriptase Inhibitor Drugs in Women Given Intrapartum Nevirapine for Perinatal HIV Prevention: An Open-label Randomised Trial." Lancet, vol. 370, no. 9600, 2007, p. 1698, https://doi.org/10.1016/s0140-6736(07)61605-5.